MetLife Investment Management’s Akcea Therapeutics, Inc. Common Stock AKCA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-7,945
| Closed | -$144K | – | 2352 |
|
|
2020
Q3 | $144K | Buy |
7,945
+589
| +8% | +$10.7K | ﹤0.01% | 2045 |
|
|
2020
Q2 | $101K | Hold |
7,356
| – | – | ﹤0.01% | 2252 |
|
|
2020
Q1 | $105K | Hold |
7,356
| – | – | ﹤0.01% | 2046 |
|
|
2019
Q4 | $125K | Hold |
7,356
| – | – | ﹤0.01% | 2214 |
|
|
2019
Q3 | $113K | Hold |
7,356
| – | – | ﹤0.01% | 2271 |
|
|
2019
Q2 | $172K | Hold |
7,356
| – | – | ﹤0.01% | 2117 |
|
|
2019
Q1 | $208K | Hold |
7,356
| – | – | ﹤0.01% | 1961 |
|
|
2018
Q4 | $222K | Hold |
7,356
| – | – | ﹤0.01% | 1854 |
|
|
2018
Q3 | $258K | Buy |
+7,356
| New | +$258K | ﹤0.01% | 1946 |
|
|
2018
Q2 | – | Sell |
-7,356
| Closed | -$188K | – | 2248 |
|
|
2018
Q1 | $188K | Sell |
7,356
-4,106
| -36% | -$105K | ﹤0.01% | 1924 |
|
|
2017
Q4 | $199K | Buy |
+11,462
| New | +$199K | ﹤0.01% | 1928 |
|